Xortx Therapeutics Stock Price on September 24, 2024
| XRTX Stock | USD 1.27 0.06 4.96% |
Below is the normalized historical share price chart for XORTX Therapeutics extending back to November 28, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of XORTX Therapeutics stands at 1.27, as last reported on the 1st of December, with the highest price reaching 1.32 and the lowest price hitting 1.27 during the day.
If you're considering investing in XORTX Stock, it is important to understand the factors that can impact its price. XORTX Therapeutics shows Sharpe Ratio of -0.091, which attests that the company had a -0.091% return per unit of risk over the last 3 months. XORTX Therapeutics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XORTX Therapeutics' Market Risk Adjusted Performance of 0.5473, mean deviation of 7.45, and Downside Deviation of 7.87 to validate the risk estimate we provide.
At this time, XORTX Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 5.8 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 3.1 M in 2024. . Price Earnings Ratio is likely to drop to -2.11 in 2024. Price Book Value Ratio is likely to drop to 0.89 in 2024. XORTX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of November 2018 | 200 Day MA 2.3314 | 50 Day MA 1.5809 | Beta (0.21) |
XORTX |
Sharpe Ratio = -0.091
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XRTX |
Estimated Market Risk
| 6.91 actual daily | 61 61% of assets are less volatile |
Expected Return
| -0.63 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average XORTX Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XORTX Therapeutics by adding XORTX Therapeutics to a well-diversified portfolio.
Price Book 1.9188 | Book Value 2.322 | Enterprise Value 2.1 M | Enterprise Value Ebitda 0.0864 | Shares Float 2.7 M |
Related Headline
Ensysce Biosciences Headline on 24th of September 2024
Ensysce Biosciences Presenting at Upcoming Meetings by finance.yahoo.com
New Data on Opioid Use Disorder Program at Society for Neuroscience Meeting Ensysce CEO Invited Expert Speaker at Formulation Delivery US 2024 Meeting SAN DIEGO, CA ACCESSWIRE September 24, 2024 Ensysce Biosciences, Inc. ...
XORTX Therapeutics Valuation on September 24, 2024
It is possible to determine the worth of XORTX Therapeutics on a given historical date. On September 24, 2024 XORTX was worth 1.65 at the beginning of the trading date compared to the closed value of 1.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XORTX Therapeutics stock. Still, in general, we apply an absolute valuation method to find XORTX Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XORTX Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XORTX Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.68 | 1.73 | 1.62 | 1.64 | 20,393 | |
09/24/2024 | 1.65 | 1.73 | 1.57 | 1.64 | 31,644 |
| 1.67 | 1.73 | 1.55 | 1.71 | 7,579 |
| Backtest XORTX Therapeutics | | | XORTX Therapeutics History | | | XORTX Therapeutics Valuation | Previous | Next |
XORTX Therapeutics Trading Date Momentum on September 24, 2024
| On September 25 2024 XORTX Therapeutics was traded for 1.71 at the closing time. The top price for the day was 1.73 and the lowest listed price was 1.55 . The trading volume for the day was 7.6 K. The trading history from September 25, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 4.27% . The trading price change against the current closing price is 0.61% . |
XORTX Therapeutics Fundamentals Correlations and Trends
By evaluating XORTX Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XORTX Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XORTX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About XORTX Therapeutics Stock history
XORTX Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XORTX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XORTX Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XORTX Therapeutics stock prices may prove useful in developing a viable investing in XORTX Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2 M | 2.1 M | |
| Net Loss | -8.5 M | -8.1 M |
XORTX Therapeutics Stock Technical Analysis
XORTX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
XORTX Therapeutics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
XORTX Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
XORTX Therapeutics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how XORTX Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XORTX Therapeutics shares will generate the highest return on investment. By undertsting and applying XORTX Therapeutics stock market strength indicators, traders can identify XORTX Therapeutics entry and exit signals to maximize returns
XORTX Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XORTX Therapeutics' price direction in advance. Along with the technical and fundamental analysis of XORTX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XORTX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0588 | |||
| Jensen Alpha | 0.8881 | |||
| Total Risk Alpha | (1.88) | |||
| Sortino Ratio | 0.1317 | |||
| Treynor Ratio | 0.5373 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.